The Company has four groups representing various major therapeutic classes such as Ophthalmology, Neuro-psychiatry, Pulmonology, ENT, Gastroenterology etc. Now the presence in neuro-psychiatry has been further strengthened by introducing various advance molecules.
Providing Quality products at affordable prices since 1951
Current economic and social stresses are exposing the people to many psychological and neurological disorders. So to explore this opportunity SPL decided to develop a companionship with neuropsychiatric specialists by introducing diverse products in neuropsychiatry. Along with them a latest quinolone, gemifloxacin, has also been launched for the treatment of respiratory tract infections.
The new additions in current product portfolio are; Cercolin (Citicoline), Qutapin (Quetiapine), Naze (Clonazepam), Lamprene (Lamotrigine), Mantex (Memantine) Qflox (Gemifloxacin).